February 2, 2017

DSN associate editor David Salazar examines the state of the pharmacy industry, including generics, automation and technology, in this multi-page report.

 

January 4, 2017

DSN associate editor David Salazar examines the state of the pharmacy industry in this multi-page report.

December 7, 2016

DSN associate editor David Salazar examines chain pharmacy, including in-depth coverage of automation and technology, in this multi-page report.

November 14, 2016

DSN associate editor David Salazar examines chain pharmacy, including in-depth coverage of generics, in this multi-page report.

August 3, 2016

DSN associate editor David Salazar examines chain pharmacy, including in-depth coverage of pharmacy spending, telehealth, generics and technology, in this multi-page report.

June 1, 2016

DSN associate editor David Salazar examines chain pharmacy, including in-depth coverage of pharmacy technology, in this multi-page report.

April 14, 2016

DSN examines chain pharmacy, including in-depth coverage of specialty pharmacy, orphan drugs and biosimilars, in this multi-page report.

 

December 30, 2015

DSN examines chain pharmacy, including in-depth coverage of generics, specialty pharmacy and top trends, in this multi-page report.

December 9, 2015

DSN examines chain pharmacy, including in-depth coverage of generics, technology, automation, prescription drug home delivery services and Web-based diabetes monitoring, in this multi-page report.

November 11, 2015

DSN examines chain pharmacy, including in-depth coverage of generics, regulations, technology, automation and medication synchronization, in this multi-page report.

October 13, 2015

DSN examines chain pharmacy, including in-depth coverage of retail clinics, technology, automation, medication synchronization and generics, in this multi-page report.

September 25, 2015

Learning together with other health professionals might become more mainstream for pharmacists, according to a report published Friday by the International Pharmaceutical Federation Education Initiative.

September 11, 2015

DSN examines chain pharmacy, including in-depth coverage of retail clinics, technology, automation, medication synchronization and generics, in this multi-page report.

August 20, 2015

DSN examines chain pharmacy, including in-depth coverage of retail clinics, technology, automation, medication synchronization and generics, in this multi-page report.

August 7, 2015

A new World Health Organization report amid the largest outbreak of Ebola ever recorded describes “a promising Ebola vaccine candidate,” identified by a trial in Guinea.

July 15, 2015

DSN examines chain pharmacy, including in-depth coverage of technology, automation, medication synchronization and generics, in this multi-page report.

June 15, 2015

DSN examines chain pharmacy, including in-depth coverage of technology, automation and generics, in this multi-page report.

May 19, 2015

DSN examines chain pharmacy — including in-depth coverage of retail clinics, generics, consolidations, kiosks and more — in this multi-page report.

April 20, 2015

DSN examines chain pharmacy — including in-depth coverage of provider status, generics, pharmacy deserts, point-of-care testing and more — in this multi-page report.

April 20, 2015

Professions Quest launches a massively multi-player online serious game called Mimycx to help educate healthcare professionals.

March 9, 2015

DSN examines chain pharmacy, including in-depth coverage of provider status, kiosks, Medicare and the GPhA elections, in this multi-page report.

February 4, 2015

DSN examines chain pharmacy, including in-depth coverage of telehealth, generic drug prices, and the GPhA CEO to step down, as well as Uhl appointed director of OGD, in this multi-page report.

January 5, 2015

DSN examines chain pharmacy, including in-depth coverage of pharmacy technology, biosimilars and generics, as well as a Q&A with Owen Mumford's Travis Shaw, in this multi-page report.

December 12, 2014

DSN examines chain pharmacy, including in-depth coverage of pharmacy technology, biosimilars and generics, as well as a look at FDA reform and its potential impact on healthcare costs, in this multi-page report.